Shareholders that lost money on Novo Nordisk A/S(NVO) Urged to Join Class Action - Contact The Gross Law Firm to Learn MorePRNewsWire • 08/21/25
The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to KnowThe Motley Fool • 08/21/25
NVO STOCK: Robbins LLP Reminds NVO Stockholders of the Opportunity to Lead the Class Action Lawsuit Against Novo Nordisk A/SPRNewsWire • 08/20/25
Novo Nordisk to present Wegovy® and Ozempic® data showing life-saving cardiovascular benefits for people living with obesity and type 2 diabetes at the European Society of Cardiology Congress 2025GlobeNewsWire • 08/20/25
Contact Levi & Korsinsky by September 30, 2025 Deadline to Join Class Action Against Novo Nordisk A/S(NVO)PRNewsWire • 08/19/25
BioMed X and Novo Nordisk Launch New Collaboration in Oral Peptide Drug DeliveryNewsfile Corp • 08/19/25
INVESTOR REMINDER: Berger Montague Notifies Novo Nordisk A/S (NYSE: NVO) Investors of a Class Action Lawsuit and DeadlinePRNewsWire • 08/18/25
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with HimsFast Company • 08/18/25